ENDV Stock Price, Chart, Stats & News

Endonovo Therapeutics, Inc.
Save
Endonovo Therapeutics, Inc. (ENDV) does not currently pay a dividend.
31,875
Market cap
–
Current P/E
–
Forward P/E
ENDV chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Endonovo Therapeutics, Inc., a biotechnology company, specializes in the development, manufacturing, and distribution of non-invasive electroceutical medical devices designed for regenerative medicine applications. The company's primary offering is SofPulse, an advanced non-invasive therapeutic device that employs electroceutical technology. SofPulse is engineered to provide palliative relief for various conditions, including soft tissue injuries, chronic wounds, and post-operative pain and edema.
Similar securities
Based on sector and market capitalization
Report issue





